WCM
AMED

Whitener Capital Management’s Amedisys AMED Stock Holding History

Whitener Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-88
Closed -$11K – 154
2019
Q3 		$11K Hold
88
– – 0.01% 344
2019
Q2 		$10K Buy
88
+70
+389% +$8.31K 0.01% 346
2019
Q1 		$2K Hold
18
– – ﹤0.01% 423
2018
Q4 		$2K Buy
+18
New +$2.12K ﹤0.01% 398

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Whitener Capital Management's AMED Position: Q4 2019 in Review

Whitener Capital Management sold out of Amedisys (AMED) in Q4 2019, closing a stake of 88 shares — an estimated $11K sold.

Whitener Capital Management first reported a position in AMED in Q4 2018 and held it in 4 quarters. The position peaked at $11K in Q3 2019. 325 funds tracked by Wall St. Rank hold AMED as of Q4 2019.

  • Whitener Capital Management reported no remaining Amedisys position as of Q4 2019 after selling out during the quarter.
  • Whitener Capital Management sold 88 Amedisys shares in Q4 2019, an estimated $11K.
  • Whitener Capital Management first reported a position in Amedisys in Q4 2018 and held it in 4 quarters.
  • Whitener Capital Management's Amedisys position peaked at $11K in Q3 2019.
  • 325 funds tracked by Wall St. Rank held Amedisys as of Q4 2019.

Based on Whitener Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.